aspartic acid has been researched along with Thrombopenia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alberts, SR; Berenberg, JL; Diasio, RB; Goldberg, RM; Lee, AM; Pavey, E; Sargent, DJ; Shi, Q; Sinicrope, FA | 1 |
| Dasari, S; Naha, K; Prabhu, M | 1 |
| Cummings, CL; Drachman, JG; Gandhi, MJ | 1 |
| Coren, A; Glick, JH; Muggia, FM; O'Connell, MJ; Opfell, RW; Tsiatis, AA | 1 |
| Beecham, J; Bundy, B; DiSaia, PJ; Muss, HB; Stehman, FB | 1 |
| Gorczynski, RJ; King, LW; Miyano, M; Nicholson, NS; Panzer-Knodle, SG; Salyers, AK; Taite, BB; Tjoeng, FS; Williams, MH; Zupec, ME | 1 |
1 trial(s) available for aspartic acid and Thrombopenia
| Article | Year |
|---|---|
DPYD variants as predictors of 5-fluorouracil toxicity in adjuvant colon cancer treatment (NCCTG N0147).
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Camptothecin; Chemotherapy, Adjuvant; Colonic Neoplasms; Diarrhea; Dihydrouracil Dehydrogenase (NADP); Drug-Related Side Effects and Adverse Reactions; Female; Fluorouracil; Genetic Predisposition to Disease; Humans; Leucovorin; Logistic Models; Male; Middle Aged; Nausea; Neoplasm Staging; Neutropenia; Organoplatinum Compounds; Polymorphism, Single Nucleotide; Prospective Studies; Severity of Illness Index; Thrombocytopenia; Valine; Vomiting | 2014 |
5 other study(ies) available for aspartic acid and Thrombopenia
| Article | Year |
|---|---|
Spectrum of complications associated with Plasmodium vivax infection in a tertiary hospital in South-Western India.
Topics: Adult; Alanine Transaminase; Anemia; Aspartic Acid; Biomarkers; Creatine Kinase; Creatinine; Female; Humans; Hypoalbuminemia; India; Leukopenia; Malaria, Vivax; Male; Medical Records; Plasmodium vivax; Retrospective Studies; Thrombocytopenia | 2012 |
FLJ14813 missense mutation: a candidate for autosomal dominant thrombocytopenia on human chromosome 10.
Topics: Amino Acid Substitution; Aspartic Acid; Blotting, Southern; Chromosomes, Human, Pair 10; Genes, Dominant; Genotype; Glutamic Acid; Haplotypes; Humans; Microsatellite Repeats; Microtubule-Associated Proteins; Mutation, Missense; Phenotype; Protein Serine-Threonine Kinases; Thrombocytopenia | 2003 |
Phase II trial of PALA in lymphoma: an Eastern Cooperative Oncology Group study.
Topics: Adult; Aged; Aspartic Acid; Digestive System; Drug Eruptions; Drug Evaluation; Female; Humans; Leukopenia; Lymphoma; Male; Middle Aged; Organophosphorus Compounds; Phosphonoacetic Acid; Thrombocytopenia; Thromboembolism | 1984 |
PALA (NSC-224131) in advanced carcinoma of the cervix. A phase II study of the Gynecologic Oncology Group.
Topics: Adult; Aged; Aspartic Acid; Drug Evaluation; Female; Humans; Leukopenia; Middle Aged; Organophosphorus Compounds; Phosphonoacetic Acid; Thrombocytopenia; Uterine Cervical Neoplasms | 1984 |
In vitro and in vivo effects of a peptide mimetic (SC-47643) of RGD as an antiplatelet and antithrombotic agent.
Topics: Amino Acid Sequence; Animals; Aspartic Acid; Dogs; Fibrinogen; Fibrinolytic Agents; Guanidines; Humans; In Vitro Techniques; Molecular Sequence Data; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Thrombocytopenia | 1991 |